Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Neurology
Disease Category: Parkinson's Disease
Trial Information
UVa Health System, Department of Neurology, seeks Woman and Men with Parkinsons Disease for research study.
The purpose of the study is to evaluate whether creatine is more effective than placebo in slowing clinical worsening in patients with Parkinsons Disease. The study involves taking creatine or placebo twice a day, blood draws, assessment of Parkinsons symptoms, completion of surveys, and testing of thinking skills. Participants are seen initially every 3 months, extending to every 6 months, some of which are phone visits. The trial last for at least 5 years. Clinic visits are at the Fontaine Adult Neurology Clinic. Participants must be within 5 years of their diagnosis and have been treated with levodopa or a dopamine agonist for less than 2 years.
Study-related exams, tests and experimental medication provided free of charge.
No compensation is provided for this study.
Contact Information:
For more information please contact:
Insert Margaret Keller RN MS
Phone 434-243-5457; email mfk8e@virginia.edu
Insert IRB-HSR # 12781
Principal Investigator: G. Frederick Wooten, Jr. MD
www.healthsystem.virginia.edu/clinical_trials
Margaret Keller RN, CCRC
University of Virginia
School of Medicine
General Neurology, Neurology
Box 801018
Charlottesville, VA 22908
Phone: 434-243-5457
EMail: mfk8e@virginia.edu
View Google Map
Research Center Information: University of Virginia
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
